Controversial fentanyl lollipops and similar products will no longer be made by drug makers, the U.S. Food and Drug ...

Drugmaker Cephalon had the FDA's approval to market these drugs, old under brand names like Actiq, as a sweetened lozenge on ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced new positive efficacy, safety and ...

In late June, generic drug maker Teva Pharmaceuticals launched a generic version of Victoza, a blockbuster diabetes drug, in ...

And then the drug for MSA, which, if it's efficacious ... And I go back to what I said earlier, from a Teva point of view, that could be really meaningful that I see us have a contribution, and it ...

The stock climbs 6.2% in response. Teva stock jumped early Wednesday after generic drugs helped drive a second-quarter beat. The company also raised its outlook. Although the revenue and EPS for ...

The long-term safety of TEV-‘749 and incidence of PDSS are also being evaluated in the SOLARIS open-label study (Period 2), with safety data topline readout expected in the first half of 2025.

Despite FDA restrictions, drugmakers, including Cephalon and later its parent company Teva pharmaceuticals, faced lawsuits for downplaying the drug's addiction risks and promoting the medication to ...

Peoria County has secured more than $1.1 million in settlement cases with three major pharmaceutical companies filed during ...

The Health Resources and Services Administration threatened Johnson & Johnson with fines and exclusion from the 340B Drug ...

Would-be dads taking drugs to stop their epilepsy seizures—and valproate in particular—should be largely reassured that the available evidence on the developmental risks to their offspring doesn’t ...

Organon is set to acquire Roivant Sciences' Dermavant Sciences, known for developing immuno-dermatology treatments, including ...